Application of cyberknife in treatment of retroperitoneal lymph node metastatic tumors in 81 cases
Lian Zuping,Xie Youke,Tang Yang,Cheng Tao,Luo Shuang,Bai Guangde
Department of Oncology (Lian ZP,Xie YK,Luo S,Bai GD),Department of Radiation Oncology (Tang Y,Cheng T),Ruikang Hospital Affiliated to Guangxi University of Traditional Chinese Medicine,Nanning 530011,China
Abstract： Objective To evaluate the clinical efficacy and side effects of cyberknife therapy in the treatment of retroperitoneal lymph node metastatic tumor. Methods Among the 81 patients presenting with postoperative retroperitoneal lymph node metastases,33 cases suffered from abdominal pain or low back pain,7 had unilateral hydronephrosis and ureteral dilatation,and 8 developed unilateral or bilateral lower limb swelling. Using stereotactic radiotherapy with a cyberknife,DT was delivered at 33-45 Gy/3-6 F.The improvement of symptoms,objective tumor response rate,and irradiation-induced side effects were observed. Results At 4 weeks after treatment,pain and swelling of the lower extremities were completely mitigated,and hydronephrosis was fully healed in all patients. Enhanced CT or MRI was performed every 2 to 3 months. After 6-month follow-up,the complete response (CR) rate was calculated as 77%(62/81),21%(17/81) for the partial response (PR) rate,3%(2/81) for the stable disease (SD) rate and the effective rate (CR+PR) was 98%.No case progressed. The main side effect was intestinal injury,including grade 1 in 16%(13/81),grade 2 in 9%(7/81).Multivariate analysis demonstrated the CR rate was not correlated with the type of the primary tumor or the size of the tumor (P>0.05),but was significantly associated with the distance of>0.5 cm between the tumor and intestine and the BED (α/β=10)>70 Gy of the tumor irradiation (P<0.01).The incidence of irradiation-related side effects was correlated with the maximum diameter of tumor>5 cm and the distance of<0.5 cm between the tumor and intestine (P<0.01). Conclusions Cyberknife is an efficacious and safe approach in the treatment of retroperitoneal lymph node metastatic tumors.
Lian Zuping,Xie Youke,Tang Yang et al. Application of cyberknife in treatment of retroperitoneal lymph node metastatic tumors in 81 cases[J]. Chinese Journal of Radiation Oncology, 2018, 27(8): 749-752.
[1] Awano N,Ikushima S,Izumo T,et al. Efficacy and safety of stereotactic body radiotherapy using CyberKnife in Stage Ⅰ primary lung tumor[J].Jpn J Clin Oncol,2017,47(10):969-975.DOI:10.1093/jjco/hyx100. [2] Zhu X,Li F,Ju X,et al. Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer[J].Cancer Med,2017,6(10):2263-2270.DOI:10.1002/cam4.1164. [3] Yamazaki H,Ogita M,Himei K,et al. Effect of intratumoral abscess/necrosis on the outcome for head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife[J].Mol Clin Oncol,2017,7(3):336-340.DOI:10.3892/mco.2017.1339. [4] Su TS,Liang P,Lu HZ,et al. Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients[J].J Surg Oncol,2016,113(2):181. [5] 于金明,谢印法,于甬华,等。立体定向放射结合介入治疗腹膜后转移癌[J].中华放射肿瘤学杂志,2001,10(1):60-61. Yu JM,Xie YF,Yu YH,et al. Stereotactic radiotherapy combined with interventional therapy for retroperitoneal metastatic carcinoma[J].Chin J Radit Oncol,2001,10(1):60-61. [6] 葛宁,詹必红,常娜,等.替吉奥联合伽马刀治疗食管癌腹膜后淋巴结转移的临床观察[J].蚌埠医学院学报,2015,40(10):1346-1349.DOI:10.13898/j.cnki.issn.1000-2200.2015.10.017. Ge N,Zhan BH,Chang N,et al. Clinical observation of tigeo combined with gamma knife in the treatment of retroperitoneal lymph Node Metastasis of esophageal carcinoma[J].J Bengbu Med College,2015,40(10):1346-1349.DOI:10.13898/j.cnki.issn.1000-2200.2015.10.017. [7] Zhuang HQ,Yuan ZY,Song YC,et al. Clinical observation on the efficacy of CyberKnife for primary or metastatic retroperitoneal tumours[J].Eur J Cancer Care (Engl),2014,23(1):76-81.DOI:10.1111/ecc.12112. [8] Wang Z,Lu J,Gong J,et al. CT-guided radioactive 125I seed implantation therapy of symptomatic retroperitoneal lymph node metastases[J].Cardiovasc Intervent Radiol,2014,37(1):125-131.DOI:10.1007/s00270-013-0613-3. [9] Faria EF,Neves HS,Dauster B,et al. Laparoscopic retroperitoneal lymph node dissection as a safe procedure for postchemotherapy residual mass in testicular cancer[J].J Laparoendosc Adv Surg Tech A,2017,28(2):168-173.DOI:10.1089/lap.2017.0381. [10] 庞军,陈燕.体部立体定向放疗治疗腹膜后转移瘤临床疗效观察[J].现代肿瘤医学,2017,25(9):1454-1456.DOI:10.3969/j.issn.1672-4992.2017.09.029. Pang J,Chen Y.Clinical efficacy of stereotactic radiotherapy for retroperitoneal metastases[J].Mod Oncol Med,2017,25(9):1454-1456.DOI:10.3969/j.issn.1672-4992.2017.09.029.
2018, Vol. 27 
